On February 27, 2020, the FDA approved an intravenous solution of amisulpride (Barhemsys; Acacia Pharma) to treat and prevent postoperative nausea and vomiting.
John Kassis, PharmD
Advertisement
Articles by John Kassis, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol
2
Pharmacists May Field Questions Regarding Cyclosporiasis Outbreak
3
Lowered Pneumococcal Vaccination Age Has Yet to Close Awareness Gap
4
How Pharmacists Take Control of Medical Billing
5